Li-fang Wang
Kaohsiung, KHQ, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 63 publications
The addition of celecoxib enhances the therapeutic benefit of cabozantinib and anti-PD1 in hepatocellular carcinoma.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: November 21, 2025
Ethanol inhibits the growth and metastasis of hepatocellular carcinoma by inducing immunogenic cell death.
Journal: Journal for immunotherapy of cancer
Published: February 05, 2025
Prolonged DEHP exposure enhances the stemness and metastatic potential of TNBC cells in an MSI2-dependent manner.
Journal: International journal of biological sciences
Published: July 29, 2024
Immunotherapy Study on Non-small-Cell Lung Cancer (NSCLC) Combined with Cytotoxic T Cells and miRNA34a.
Journal: Molecular pharmaceutics
Published: January 31, 2024
Comparing the Variants of Iron Oxide Nanoparticle-Mediated Delivery of miRNA34a for Efficiency in Silencing of PD-L1 Genes in Cancer Cells.
Journal: Pharmaceutics
Published: December 01, 2022
Serum Mediators in Patients with Both Type 2 Diabetes Mellitus and Pruritus.
Journal: Acta dermato-venereologica
Published: October 12, 2022
In situ vaccination followed by intramuscular poly-ICLC injections for the treatment of hepatocellular carcinoma in mouse models.
Journal: Pharmacological research
Published: October 04, 2022
Neoantigen vaccination augments antitumor effects of anti-PD-1 on mouse hepatocellular carcinoma.
Journal: Cancer letters
Published: August 11, 2022
Neuropeptide-Functionalized Gold Nanorod Enhanced Cellular Uptake and Improved In Vitro Photothermal Killing in LRP1-Positive Glioma Cells.
Journal: Pharmaceutics
Published: July 26, 2022
Near-Infrared Light-Triggered Drug Release from Ultraviolet- and Redox-Responsive Polymersome Encapsulated with Core-Shell Upconversion Nanoparticles for Cancer Therapy.
Journal: ACS applied bio materials
Published: January 11, 2022
Last Updated: 09/26/2026